Alambic Investment Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-21,100
Closed -$784K – 308
2019
Q1
$784K Sell
21,100
-6,550
-24% -$238K 0.32% 116
2018
Q4
$780K Buy
27,650
+18,940
+217% +$599K 0.33% 113
2018
Q3
$344K Sell
8,710
-2,990
-26% -$131K 0.27% 132
2018
Q2
$519K Buy
+11,700
New +$582K 0.14% 204
2017
Q4
– Sell
-30,780
Closed -$1.56M – 463
2017
Q3
$1.56M Sell
30,780
-12,400
-29% -$585K 0.17% 194
2017
Q2
$1.64M Sell
43,180
-15,400
-26% -$607K 0.2% 175
2017
Q1
$2.25M Sell
58,580
-30,820
-34% -$928K 0.28% 112
2016
Q4
$1.98M Buy
+89,400
New +$1.84M 0.35% 77
2016
Q1
– Sell
-10,900
Closed -$58K – 490
2015
Q4
$58K Buy
+10,900
New +$69.7K 0.03% 352

Other funds holding CC

Alambic Investment Management's CC Position: Q2 2019 in Review

Alambic Investment Management sold out of Chemours (CC) in Q2 2019, closing a stake of 21,100 shares — an estimated $784K sold.

Alambic Investment Management first reported a position in CC in Q4 2015 and held it in 9 quarters. The position peaked at $2.25M in Q1 2017. 488 funds tracked by Wall St. Rank hold CC as of Q2 2019.

  • Alambic Investment Management reported no remaining Chemours position as of Q2 2019 after selling out during the quarter.
  • Alambic Investment Management sold 21,100 Chemours shares in Q2 2019, an estimated $784K.
  • Alambic Investment Management first reported a position in Chemours in Q4 2015 and held it in 9 quarters.
  • Alambic Investment Management's Chemours position peaked at $2.25M in Q1 2017.
  • 488 funds tracked by Wall St. Rank held Chemours as of Q2 2019.

Based on Alambic Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.